LAVA Therapeutics NV

NASDAQ:LVTX   3:52:37 PM EDT
1.55
0.00 (+0.32%)
4:04:02 PM EDT: $1.54 -0.01 (-0.32%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

LAVA Therapeutics NV Stock, NASDAQ:LVTX

Yalelaan 62, Utrecht, Noord-Brabant 3584 CM
Netherlands
Phone: +31.85.016.31.00
Number of Employees: 37

Description

LAVA Therapeutics NV is an immuno-oncology company, which engages in the proprietary Gammabody platform to develop a portfolio of bispecific gamma delta T cell engagers for the potential treatment of solid tumors and hematological malignancies. The company was founded by Erik van den Berg in 2016 and is headquartered in Utrecht, the Netherlands.